The Effect of Subcutaneous Treprostinil on Pulmonary Hypertension Associated with Interstitial Lung Disease

被引：0
|
作者：
Sadushi-Kolici, Roela [1 ]
Shafran, Inbal [2 ]
Prosch, Helmut [3 ]
Skoro-Sajer, Nika [1 ]
Gerges, Christin [1 ]
Lang, Irene [1 ]
机构：
[1] Med Univ Vienna, Cardiol, Internal Med 2, Vienna, Austria
[2] Sheba Med Ctr, Ramat Gan, Israel
[3] Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria
来源：
EUROPEAN RESPIRATORY JOURNAL | 2023年 / 62卷
关键词：
D O I：
10.1183/13993003.congress-2023.PA3487
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Subcutaneous Treprostinil for Pulmonary Hypertension in Chronic Lung Disease of Infancy
    Ferdman, Dina J.
    Rosenzweig, Erika B.
    Zuckerman, Warren A.
    Krishnan, Usha
    PEDIATRICS, 2014, 134 (01) : E274 - E278
  • [2] Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease
    Waxman, Aaron
    Restrepo-Jaramillo, Ricardo
    Thenappan, Thenappan
    Ravichandran, Ashwin
    Engel, Peter
    Bajwa, Abubakr
    Allen, Roblee
    Feldman, Jeremy
    Argula, Rahul
    Smith, Peter
    Rollins, Kristan
    Deng, Chunqin
    Peterson, Leigh
    Bell, Heidi
    Tapson, Victor
    Nathan, Steven D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (04): : 325 - 334
  • [3] COMPARISON OF EFFECTS OF INHALED TREPROSTINIL ON LUNG FUNCTION IN PATIENTS WITH PULMONARY HYPERTENSION ASSOCIATED WITH INTERSTITIAL LUNG DISEASE AND PULMONARY ARTERIAL HYPERTENSION
    Nathan, Steven
    Tapson, Victor
    Ramani, Gautam
    Medarov, Boris
    Levine, Deborah
    Burger, Charles
    El-Kersh, Karim
    Shen, Eric
    Rao, Youlan
    Smith, Peter
    Waxman, Aaron
    CHEST, 2021, 160 (04) : 2244A - 2246A
  • [4] Inhaled Treprostinil in Pulmonary Hypertension Associated with Lung Disease
    Faria-Urbina, Mariana
    Oliveira, Rudolf K. F.
    Agarwal, Manyoo
    Waxman, Aaron B.
    LUNG, 2018, 196 (02) : 139 - 146
  • [5] Inhaled Treprostinil in Pulmonary Hypertension Associated with Lung Disease
    Mariana Faria-Urbina
    Rudolf K. F. Oliveira
    Manyoo Agarwal
    Aaron B. Waxman
    Lung, 2018, 196 : 139 - 146
  • [6] Vasoreactivity and inhaled treprostinil response in interstitial lung disease pulmonary hypertension
    Harder, Eileen M.
    Rahaghi, Farbod N.
    Leopold, Jane A.
    Systrom, David M.
    Washko, George R.
    Waxman, Aaron B.
    ERJ OPEN RESEARCH, 2024, 10 (06)
  • [7] Tolerance and Efficacy of Dry Powder Inhaler Treprostinil in Pulmonary Hypertension Associated With Interstitial Lung Disease
    Tallavajhala, S.
    Turgut, A. O.
    Khangoora, V.
    Wilkinson, J.
    Thomas, C. A.
    Nyquist, A. S.
    Singhal, A. L.
    Aryal, S.
    Nathan, S. D.
    King, C. S.
    Shlobin, O. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [8] Efficacy, safety, and pharmacokinetics of inhaled treprostinil in Japanese patients with pulmonary hypertension associated with interstitial lung disease
    Sakao, Seiichiro
    Kondoh, Yasuhiro
    Kinoshita, Hideyuki
    Nishiyama, Osamu
    Ogo, Takeshi
    Tanabe, Nobuhiro
    Minatsuki, Shun
    Nakayama, Kazuhiko
    Taniguchi, Yu
    Takahashi, Kenta
    Takatsu, Masahiro
    Ogura, Takashi
    RESPIRATORY INVESTIGATION, 2024, 62 (06) : 980 - 986
  • [9] Treprostinil and Clinical Outcome in Pulmonary Hypertension and Interstitial Lung Disease Is All Clear?
    Carbone, Roberto G.
    Monselise, Assaf
    Puppo, Francesco
    CHEST, 2023, 164 (01) : e21 - e21
  • [10] Inhaled Treprostinil Dosage in Pulmonary Hypertension Associated With Interstitial Lung Disease and Its Effects on Clinical Outcomes
    Nathan, Steven D.
    Deng, Chunqin
    King, Christopher S.
    DuBrock, Hilary M.
    Elwing, Jean
    Rajagopal, Sudarshan
    Rischard, Franz
    Sahay, Sandeep
    Broderick, Meredith
    Shen, Eric
    Smith, Peter
    Tapson, Victor F.
    Waxman, Aaron B.
    CHEST, 2023, 163 (02) : 398 - 406
12345